UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

British journal of dermatology (1951), 2015-10, Vol.173 (4), p.930-939

2015

Volltextzugriff (PDF)

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

Journal of the European Academy of Dermatology and Venereology, 2021-02, Vol.35 (2), p.476-485

2021

Volltextzugriff (PDF)

Analysis of anti‐tumour necrosis factor‐induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics

British journal of dermatology (1951), 2018-05, Vol.178 (5), p.1151-1162

2018

Volltextzugriff (PDF)

Comments on ‘French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults’

Journal of the European Academy of Dermatology and Venereology, 2019-09, Vol.33 (9), p.e310-e310

2019

Volltextzugriff (PDF)

Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks

Journal of the European Academy of Dermatology and Venereology, 2023-09, Vol.37 (9), p.1825-1840

2023

Volltextzugriff (PDF)

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis

Journal of the European Academy of Dermatology and Venereology, 2022-09, Vol.36 (9), p.1486-1496

2022

Volltextzugriff (PDF)

Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Dermatology and therapy, 2024-06, Vol.14 (6), p.1479-1493

2024

Volltextzugriff (PDF)

An integrated safety analysis of treatment‐emergent fungal infections in patients with psoriasis treated with ixekizumab from 16 clinical studies

Journal of the European Academy of Dermatology and Venereology, 2021-11, Vol.35 (11), p.e828-e831

2021

Volltextzugriff (PDF)

Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: integrated safety analysis from 11 clinical trials of patients with plaque psoriasis

British journal of dermatology (1951), 2019-07, Vol.181 (1), p.202-203

2019

Volltextzugriff (PDF)

Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate‐to‐severe psoriasis: a post hoc analysis from IXORA‐PEDS

Journal of the European Academy of Dermatology and Venereology, 2021-12, Vol.35 (12), p.e911-e913

2021

Volltextzugriff (PDF)

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab

The Journal of dermatological treatment, 2022-07, Vol.33 (5), p.2503-2509

2022

Volltextzugriff (PDF)

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Dermatology and therapy, 2024-06, Vol.14 (6), p.1495-1496

2024

Volltextzugriff (PDF)

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

Journal of the European Academy of Dermatology and Venereology, 2020-06, Vol.34 (6), p.1257-1262

2020

Volltextzugriff (PDF)

抗肿瘤坏死因子诱导的皮肤病变的分析揭示了辅助型T细胞1强活性以及一些显著的免疫学特性

British journal of dermatology (1951), 2018-05, Vol.178 (5), p.e383-e383

2018

Volltextzugriff (PDF)

Analysis of anti‐tumour necrosis factor‐induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics

British journal of dermatology (1951), 2018-05, Vol.178 (5), p.e364-e364

2018

Volltextzugriff (PDF)

Carnosine treatment in combination with ACE inhibition in diabetic rats

Regulatory peptides, 2014-11, Vol.194-195, p.36-40

2014

Volltextzugriff (PDF)

Prone, stereotactic, vacuum-assisted breast biopsy

European journal of cancer (1990), 2020-10, Vol.138, p.S86-S86

2020

Volltextzugriff (PDF)

Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes

The Journal of immunology (1950), 1996-11, Vol.157 (9), p.3850-3859

1996

Volltextzugriff (PDF)

Emergency Ultrasound at the Military Hospital: Our Experience

Ultrasound in medicine & biology, 2011, Vol.37 (8), p.S26-S27

2011

Volltextzugriff (PDF)

Is Fairtrade Fair?

Elisabeth Valiente-Riedl

1, 2012

Volltextzugriff (PDF)

Involvement of programmed cell death in morphogenesis of the vertebrate inner ear

Development (Cambridge), 1997-06, Vol.124 (12), p.2451-2461

1997

Volltextzugriff (PDF)

TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors

The Journal of immunology (1950), 1996-08, Vol.157 (4), p.1499-1507

1996

Volltextzugriff (PDF)

Crowdsourcing medical research

Computer (Long Beach, Calif.), 2013-01, Vol.46 (1), p.89-92

2013

Volltextzugriff (PDF)

TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis

The Journal of immunology (1950), 1997-02, Vol.158 (4), p.1591-1597

1997

Volltextzugriff (PDF)

Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas

Acta dermato-venereologica, 2018-02, Vol.98 (2), p.240-245

2018

Volltextzugriff (PDF)

1 – 25 von 1.084

Suche als RSS-Feed

Aktive Filter

SpracheItalienisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(819)
Mit Volltextzugriff
(881)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

Analysis of anti‐tumour necrosis factor‐induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics

Comments on ‘French guidelines on the use of systemic treatments for moderate‐to‐severe psoriasis in adults’

Speed of clinical improvement in the real‐world setting from patient‐reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks

An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate‐to‐severe atopic dermatitis

Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

An integrated safety analysis of treatment‐emergent fungal infections in patients with psoriasis treated with ixekizumab from 16 clinical studies

Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: integrated safety analysis from 11 clinical trials of patients with plaque psoriasis

Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate‐to‐severe psoriasis: a post hoc analysis from IXORA‐PEDS

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

抗肿瘤坏死因子诱导的皮肤病变的分析揭示了辅助型T细胞1强活性以及一些显著的免疫学特性

Analysis of anti‐tumour necrosis factor‐induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics

Carnosine treatment in combination with ACE inhibition in diabetic rats

Prone, stereotactic, vacuum-assisted breast biopsy

Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes

Emergency Ultrasound at the Military Hospital: Our Experience

Is Fairtrade Fair?

Involvement of programmed cell death in morphogenesis of the vertebrate inner ear

TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors

Crowdsourcing medical research

TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis

Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas

Aktive Filter

Suchergebnisse filtern